Arkansas’ attorney files litigation against opioid drug manufacturers
Date: 2018-03-31   Author: Saipriya Iyer  Category: #news

Arkansas’ attorney files litigation against opioid drug manufacturers

In what may seem to be a jolt to the opioid drug manufacturing firms across the U.S., Arkansas’ attorney general has filed a legal suit against Johnson & Johnson, Endo International Plc, and Purdue Pharma LP. The litigation claims that all the three drug manufacturers promoted addictive painkillers, while denying the risk associated with its use. The legal suit has made Arkansas the 17th U.S. state to file litigation against the opioid drug manufacturers amidst the ongoing addiction epidemic to the drugs across the country.

As per the litigation, these drug manufacturers spent a large amount of funds on advertising the drug benefits for treating chronic pain, while not disclosing the risks of addiction related to the drugs. Arkansas’ attorney general issued a statement claiming that these pharmaceutical giants have badly impacted the state and its residents. However, Purdue Pharma LP, a Pharma giant that manufactures OxyContin, refuted the accusations and has raised concerns over the illegal drug prescription along with the opioid drug crises. Johnson & Johnson’s Janssen Pharmaceutical unit, which manufactures the opioid Duragesic, has termed its promotional & branding activities as appropriate.

As per the U.S. Centers for Disease Control & Prevention, opioids were responsible for over 42,000 deaths in 2016 as a result of drug overdose. Though opioid drug prescription is aimed at treating acute pain, the addiction to these drugs has resulted in many legal suits being filed against the manufacturers in the U.S. Nearly 433 legal cases are pending before the U.S. District Judge in Cleveland.

In the beginning of this month, the U.S. Justice Department filing demanded thirty days for assessing the legal suit participation. It further claimed that the country has borne substantial expenditure due to the opioid epidemic. Moreover, lawyers of the petitioners have compared the potential costs of the current legal suits with the litigation filed by various states of the U.S. against the tobacco sector which led to a settlement in 1998.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Global Food Enzymes Market Grow Analysis | COVID-19 Impact, Top Players, Threats, Trends, Challenges and Opportunities till 2024
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Food Enzymes Market" 2017 - 2024 is a historical overview and detailed study on the current and future market of the Food Enzymes industry. The Food Enzymes Market was registered a...


Global Milk Fat Fractions Market Grow Analysis | COVID-19 Impact, Top Players, Threats, Trends, Challenges and Opportunities till 2024
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Milk Fat Fractions Market" 2017 - 2024 is a historical overview and detailed study on the current and future market of the Milk Fat Fractions industry. The Milk Fat Fractions Marke...


Global Fish Protein Hydrolysate Market Grow Analysis | COVID-19 Impact, Risk Factors, Challenges and Opportunities till 2026
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Fish Protein Hydrolysate Market" 2020 - 2026 is a historical overview and detailed study on the current and future market of the Fish Protein Hydrolysate industry. The Fish Protein...